Scinovex
articleTop 1% cited

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

Metabolism · 1994 · Vol. 43(5) · pp. 647–654
Elsy VelázquezSoaira MendozaT HamerFelix SosaCharles J. Glueck
Ovarian function and disordersGrowth Hormone and Insulin-like Growth FactorsBirth, Development, and HealthPolycystic ovaryHyperinsulinemiaMedicineInsulin resistanceMetforminPregnancyBlood pressureInternal medicineEndocrinologyInsulin

MeSH terms

AdultAndrogensAnthropometryBlood PressureEndocrine GlandsFemaleGonadotropinsHormonesHumansHyperinsulinismInsulin ResistanceMenstruationMetforminObesityPolycystic Ovary Syndrome
Citations
871
FWCI
24.37
field-weighted impact
References
78
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.